135 related articles for article (PubMed ID: 32518680)
1. PTPIP51 crosslinks the NFκB signaling and the MAPK pathway in SKBR3 cells.
Dietel E; Brobeil A; Tag C; Gattenloehner S; Wimmer M
Future Sci OA; 2020 Mar; 6(5):FSO463. PubMed ID: 32518680
[TBL] [Abstract][Full Text] [Related]
2. Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
Dietel E; Brobeil A; Delventhal L; Tag C; Gattenlöhner S; Wimmer M
PLoS One; 2019; 14(5):e0216642. PubMed ID: 31075141
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells.
Dietel E; Brobeil A; Tag C; Gattenloehner S; Wimmer M
Oncogenesis; 2018 Aug; 7(8):64. PubMed ID: 30139932
[TBL] [Abstract][Full Text] [Related]
4. PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway.
Brobeil A; Kämmerer F; Tag C; Steger K; Gattenlöhner S; Wimmer M
Biomolecules; 2015 Apr; 5(2):485-504. PubMed ID: 25893721
[TBL] [Abstract][Full Text] [Related]
5. The known interactome of PTPIP51 in HaCaT cells—inhibition of kinases and receptors.
Brobeil A; Koch P; Eiber M; Tag C; Wimmer M
Int J Biochem Cell Biol; 2014 Jan; 46():19-31. PubMed ID: 24501773
[TBL] [Abstract][Full Text] [Related]
6. Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling.
Brobeil A; Chehab R; Dietel E; Gattenlöhner S; Wimmer M
Biomolecules; 2017 Jul; 7(3):. PubMed ID: 28754031
[TBL] [Abstract][Full Text] [Related]
7. The Importance of the Right Framework: Mitogen-Activated Protein Kinase Pathway and the Scaffolding Protein PTPIP51.
Dietel E; Brobeil A; Gattenlöhner S; Wimmer M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360441
[TBL] [Abstract][Full Text] [Related]
8. Memory and PTPIP51--a new protein in hippocampus and cerebellum.
Brobeil A; Viard M; Petri MK; Steger K; Tag C; Wimmer M
Mol Cell Neurosci; 2015 Jan; 64():61-73. PubMed ID: 25496818
[TBL] [Abstract][Full Text] [Related]
9. PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor.
Petri MK; Brobeil A; Planz J; Bräuninger A; Gattenlöhner S; Nestler U; Stenzinger A; Paradowska A; Wimmer M
J Neurooncol; 2015 May; 123(1):15-25. PubMed ID: 25862004
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation.
Tsolou A; Liousia M; Kalamida D; Pouliliou S; Giatromanolaki A; Koukourakis M
Cancer Biol Med; 2017 Aug; 14(3):293-301. PubMed ID: 28884046
[TBL] [Abstract][Full Text] [Related]
11. PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ.
Petri MK; Koch P; Stenzinger A; Kuchelmeister K; Nestler U; Paradowska A; Steger K; Brobeil A; Viard M; Wimmer M
Histol Histopathol; 2011 Dec; 26(12):1531-43. PubMed ID: 21972092
[TBL] [Abstract][Full Text] [Related]
12. Orchestrating cellular signaling pathways-the cellular "conductor" protein tyrosine phosphatase interacting protein 51 (PTPIP51).
Brobeil A; Dietel E; Gattenlöhner S; Wimmer M
Cell Tissue Res; 2017 Jun; 368(3):411-423. PubMed ID: 27734150
[TBL] [Abstract][Full Text] [Related]
13. PTPIP51 in protein interactions: regulation and in situ interacting partners.
Brobeil A; Bobrich M; Tag C; Wimmer M
Cell Biochem Biophys; 2012 Jul; 63(3):211-22. PubMed ID: 22544307
[TBL] [Abstract][Full Text] [Related]
14. Interaction of PTPIP51 with Tubulin, CGI-99 and Nuf2 During Cell Cycle Progression.
Brobeil A; Graf M; Eiber M; Wimmer M
Biomolecules; 2012 Feb; 2(1):122-42. PubMed ID: 24970130
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes.
Stenzinger A; Schreiner D; Pfeiffer T; Tag C; Hofer HW; Wimmer M
Cells Tissues Organs; 2006; 184(2):76-87. PubMed ID: 17361080
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal squamous cell carcinoma progression is associated with the NFκB signaling pathway regulated by IκB kinase β.
Li XT
Eur Rev Med Pharmacol Sci; 2016; 20(3):467-75. PubMed ID: 26914121
[TBL] [Abstract][Full Text] [Related]
17. Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways.
Li S; Wang H; Ma R; Wang L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907830
[TBL] [Abstract][Full Text] [Related]
18. XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype.
Evans MK; Brown MC; Geradts J; Bao X; Robinson TJ; Jolly MK; Vermeulen PB; Palmer GM; Gromeier M; Levine H; Morse MA; Van Laere SJ; Devi GR
Cancer Res; 2018 Apr; 78(7):1726-1738. PubMed ID: 29351901
[TBL] [Abstract][Full Text] [Related]
19. Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways.
Pal HC; Sharma S; Strickland LR; Katiyar SK; Ballestas ME; Athar M; Elmets CA; Afaq F
PLoS One; 2014; 9(1):e86338. PubMed ID: 24466036
[TBL] [Abstract][Full Text] [Related]
20. Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells.
Ma C; Zuo W; Wang X; Wei L; Guo Q; Song X
Oncol Rep; 2013 Feb; 29(2):812-8. PubMed ID: 23229346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
